XERS FY 2017 Earnings — Xeris Biopharma Holdings, Inc. Revenue & Financial Results | Market Cap Arena

XERSXeris Biopharma Holdings, Inc.

$982M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+44.7% YoY

Gross Profit

$2M99.7% margin

Operating Income

-$27M-1711.4% margin

Net Income

-$27M-1706.6% margin

EPS (Diluted)

$-13.09

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$499,000

Balance Sheet

Total Assets

$45M

Total Liabilities

$103M

Stockholders' Equity

-$58M

Cash & Equivalents

$42M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+44.7%
Gross Profit	$2M	$1M	+45.5%
Operating Income	-$27M	-$13M	-101.3%
Net Income	-$27M	-$13M	-101.0%